
Learn the Orthosolutions 4WEB articulated total talar replacement for avascular necrosis of the whole talus surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Orthosolutions 4WEB articulated total talar replacement for avascular necrosis of the whole talus surgical procedure.
Avascular necrosis (AVN) of the talus presents a challenge to the surgeon to offer pain relief with minimal loss of function to the foot and ankle. In the event of failure of non-operative treatment methods, surgical treatment is limited by the extent of necrosis within the talus and any secondary degenerative changes to the neighbouring joints.
Avascular necrosis, also know as aseptic necrosis or osteonecrosis, of the talus is an uncommon condition. The most frequently seen aetiology is secondary to trauma with fracture either to the body or the neck of the talus accounting for 75% of cases. With these high energy injuries, there is often traumatic disruption of the tenuous blood supply either as a result of the fracture and/or by poorly planned surgical approaches to treat the injury. The remaining 25% of aetiologies are as a result of long-term corticosteroid therapy, alcoholism, hyperlipidaemia, irradiation/chemotherapy, anti-HIV therapy, thrombophilia and idiopathic causes.
The talus is particularly prone to AVN because of its precarious blood supply. It has no muscular origins or insertions and 60% of its surface area is covered in articular cartilage. It receives its blood supply from branches of the posterior tibial artery, the peroneal artery and the dorsalis pedis artery through multiple intra-osseous and extra-osseous anastomoses.
The disease process can be staged in a similar manner to avascular necrosis (AVN) of the femoral head using a modified Ficat & Arlet classification to assess radiographic findings:
I Normal
II Cystic and/or sclerotic lesions, normal talar contours, no subchondral fractures
III Crescent sign, subchondral collapse
IV Joint space narrowing, tibial cysts, osteophytes, arthrosis
In its early stages, patients may present with pain and swelling with no evidence of collapse on any forms of imaging. In these instances, most surgeons would advocate a period of cast or boot immobilisation with restrictions placed on the amount weight borne through the affected limb. A patellar tendon bearing cast may have a role in sparing weight through the diseased talus. Some papers even advocate the use of extra-corporeal shock wave therapy. As in early staging of AVN of the femoral head (stage I disease), bone and joint sparing surgeries, in terms of core decompression and either vascularised or non-vascularised bone grafting, have been described and advocated.
In stage II to III disease, in the absence of progressive arthritis or collapse of the body of the talus with minimal deformity, surgical treatment options are usually limited by the extent of osteonecrosis. For example, if the area of osteonecrosis is limited to the dome of the talus, an isolated ankle arthrodesis may be considered. This is clearly dependent upon good imaging to identify disease extent.
Total ankle replacement is relatively contra-indicated in this condition simply because any talar re-surfacing component needs a firm bony foundation on which to be seated. In my opinion, planning the surgery for this condition is entirely dependent upon being certain of the viability of the talus by using MRI and CT to assess the extent of avascularity within the bone. It is usual for the head and neck of the talus to be relatively spared of AVN. In these earlier stages of AVN the ankle, subtalar and talo-navicular joints are relatively spared.
Treatment options for stage IV disease depend upon the extent of the osteonecrosis. In the presence of collapse of the body of the talus combined with ankle and subtalar arthrosis, resection of the dead bone leaves a void that either requires grafting with bulk allograft or a custom truss as detailed on OrthOracle at https://www.orthoracle.com/library/ttc-double-fusion-using-4web-custom-talar-replacement-and-oxbridge-nail-orthosolutions/with tibio-talo-calcaneal fusion or ignoring the void and fusing the distal tibia to the calcaneus. In the presence of significant arthrosis, it may be that a total talar replacement would be less effective at achieving pain relief if it articulated against bare bone at the joint surfaces much in the way that a hip hemiarthroplasty for fracture is sore in the presence of acetabular arthrosis. This remains an unanswered question.
In this particular case, a lady in her sixth decade presented with an 18-month history of severe pain and swelling in her ankle that was exacerbated by bearing weight but was unremitting at night. With no history of injury and no other risk factors, the cause of her symptoms was diagnosed as being from idiopathic AVN of the whole of her talus. Imaging suggested whole bone involvement with cyst formation, subchondral fracturing but in the absence of degenerative changes to the neighbouring joints and with minimal deformity. With whole talar disease, the options of arthrodesis are limited to pan-talar fusion with or without filling the void left by any resected talus.
The literature offers some experience of dealing with this scenario in AVN, extensive osteochondral lesions and benign tumours of the talus using partial or total talar resection and replacement (see results section). One advantage that the talus has over most other bones is that it has no tendon origins or insertions. It is a stable intercalated segment due to its complex bony geometry and the fact that it is contained by strong capsular ligaments. Therefore, it does allow itself to be replaced by a prosthesis with a degree of confidence from the surgeon that this should be stable.
After careful discussion, my patient decided she was keen to preserve joint motion and to consider a custom-made articulated total talar replacement. The consent for this novel technique is complex insofar as the only outcome data is limited to the literature detailed later in the results section. Ultimately, failure of the talar replacement would lead to pantalar/tibio-calcaneal fusion in some format which is the other initial treatment option. In terms of following up a case such as this, I would treat this part of managing the patient in exactly the same way as a total ankle replacement with regular long term follow-up.
At present, the technology to develop total talar replacements using additive manufacturing techniques is in its relative infancy. Undoubtedly, many companies across the globe will offer this service but my rationale for choosing 4WEB was their overwhelming experience in leading the field in manufacturing prostheses that have had some follow-up in the scientific literature. In the UK 4WEB implants are supplied by Orthosolutions.

INDICATIONS
In Stage II to III of the modified Ficat & Arlet staging for AVN of the talus: In the presence of AVN affecting the whole bone but without significant collapse or arthrosis, then, to my mind, an articulated total talar replacement can be considered.
SYMPTOMS & EXAMINATION
For reasons that are unclear to me, AVN in any site is always unremittingly painful. Nocturnal pain is a red flag symptom for this condition although bearing weight often exacerbates the pain. Swelling is another significant feature, often more abundant than in degenerative conditions. In earlier stages of AVN, deformity and instability of the hindfoot are not expected features. Immobilisation in a walking boot or cast often provides security and some pain relief.
Inspection of the standing patient should look for associated deformity. The presence and site of old surgical scars are important as their positioning may influence your surgical approach for treatment. Palpation reveals areas of tenderness but motion of the ankle, subtalar and talo-navicular joints should not exhibit crepitus or stiffness.
IMAGING
For AVN, I find both CT and MRI useful to assess the bone stock, extent of bony necrosis, the involvement of both the ankle and subtalar joints and, in this case, for pre-operative planning using a custom prosthesis. To this extent, standing CT views would be the ideal gold standard.
MRI and CT assessment of the whole talus demonstrates the extent of the disease process, in particular bony collapse, deformity or arthrosis in neighbouring joints.
CT imaging of the contralateral ankle is the most reliable assesement of the normal anatomy of the talus, which is required in the planning process for the custom talar implant. It is particularly helpful in assessing the complex radii of curvature of the head of the talus.
ALTERNATIVE OPERATIVE TREATMENT
In my opinion, there are no proven alternative operative techniques for stage II to III AVN. Core decompression is unlikely to work where cyst formation and subchondral fracturing exist. The only key steps in decision making are whether there is any evidence of neighbouring joint arthritis. If there is, then some form of arthrodesis would have to be considered together with replacing the diseased area of bone.
NON-OPERATIVE MANAGEMENT
By and large, because of the degree of pain, there is little role for non-operative measures other than to afford pain relief by immobilisation in a walking boot together with good analgesia. By the time patients present, these simple measures will often have been tried. Unfortunately any swelling means that a custom-made rigid ankle-foot orthosis is unlikely to be well tolerated.
CONTRAINDICATIONS
Logically, in any patient with AVN of the whole talus, a relative contra-indication to total talar replacement surgery would be any suspicion of ankle or subtalar instability particularly in hypermobility or ligamentous laxity. Be very aware of the red, swollen and unstable foot with little pain. This presentation should raise the suspicion of a neuropathic foot undergoing a Charcot process. The management of this condition is very different and joint replacement is contraindicated. For a comprehensive review of the condition see also https://www.orthoracle.com/library/medial-column-arthrodesis-for-a-midfoot-charcot-rocker-bottom-deformity-wright-salvation-system/
Open incisions to the ankle in the presence of diabetes, vascular disease or metabolic compromise from steroid treatment are relative contra-indications for surgical intervention due to the high incidence of surgical wound breakdown.
Active infection or recent active infection and potential patient non-compliance are also to be considered contraindications to this type of surgery.

The patient is positioned supine on the operating table and may require a sandbag under the ipsilateral buttock so that the foot points vertically towards the ceiling. Fluoroscopy should be available with an image intensifier and a trained radiographer.
Appropriate antibiotics are administered and a thigh tourniquet and exclusion drape are applied. The limb is prepared with Chlorhexidine from toes to tourniquet.

The patient is placed in a below the knee back slab for the first two weeks after surgery and not permitted to bear weight. The purpose of this is to rest the surgical wound. At two weeks, after wound inspection, bearing weight in a walking boot is permitted with physiotherapy to encourage active range of motion of the ankle, subtalar and talo-navicular joints.
Rivaroxaban is prescribed for the two weeks when weight-bearing is restricted to lessen the chances of thrombo-embolic events.
At six weeks, the patient can commence bearing weight in normal footwear. At twelve weeks, the foot is assessed radiographically with standing views of the foot and ankle in three planes.

Harnroongroj T & Vanadurongwan V. The talar body prosthesis. J Bone Joint Surg 79A; 1997; 9: 1313-1322.
In this article originating from work pioneered in the 1970s, a polished stainless steel talar body replacement was fashioned based upon measurements from scanograms and implanted in patients mainly suffering from AVN talus. The design differed from a total articulating talar replacement because the design included a peg intended to be cemented into a viable talar head.
Harnroongroj T & Harnroongroj T. The talar body prosthesis: Results at ten to thirty-six years of follow-up. J Bone Joint Surg 96A; 2014; 14: 1211-1218.
The same author from the preceding paper reviews the long term results which showed an almost 85% implant survival rate at a minimum of 10 years. Early failures were thought to be as a result of an inability to measure the correct dimensions of the talus and later failures from the interface between the implant peg and the head of the talus. The paper does not cover total articulating talus replacements.
Taniguchi A, Takakura Y, Sugimoto K et al. The use of a ceramic talar body prosthesis in patients with aseptic necrosis of the talus. J Bone Joint Surg 94B; 2012; 11: 1529-1533.
This is a retrospective series of two generations of ceramic talar body replacements mainly for idiopathic AVN of the talus. In the main, these were talar body replacements with a peg designed to integrate with a viable talar head. In the small number of total articulated talus replacements, the outcomes appear superior to those prostheses designed to integrate with remaining talus. The authors conclude that replacing the whole talus leads to better outcomes than partial body replacements.
Angthong C. Anatomic total talar prosthesis replacement surgery and ankle arthroplasty: an early case series in Thailand. Orthop Rev 2014; 6: 5486; 123-7.
This case series of four only covers the outcome of one total articulated stainless steel talus replacement in a patient treated for a traumatic extruded talus. At the time of reporting the patients had good functional outcomes.
Tracey J, Arora D, Gross CE, Parekh SG. Custom 3-D printed total talar prostheses restore normal joint anatomy throughout the hindfoot. Foot & Ankle Spec; 2018; 12(1): 39-48.
This is the largest series of custom implants have since established a role for improving hindfoot anatomy in patients with AVN. All patients had a total articulated talus replacement 3D printed in nickel-plated cobalt. It s not clear whether this series included patients with Ficat stage IV disease as there are no clinical outcomes documented in the paper.
Reference
- orthoracle.com





































